GT
LH icon

Greenleaf Trust’s Labcorp LH Stock Holding History

Greenleaf Trust’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
4,592
+428
+10% +$113K 0.01% 299
2026
Q1 		$1.11M Sell
4,164
-208
-5% -$56.3K 0.01% 312
2025
Q4 		$1.1M Sell
4,372
-85
-2% -$22.6K 0.01% 310
2025
Q3 		$1.28M Buy
4,457
+4
+0.1% +$1.07K 0.01% 268
2025
Q2 		$1.17M Sell
4,453
-677
-13% -$165K 0.01% 287
2025
Q1 		$1.19M Sell
5,130
-312
-6% -$75.7K 0.01% 283
2024
Q4 		$1.25M Sell
5,442
-154
-3% -$35.3K 0.01% 276
2024
Q3 		$1.25M Buy
5,596
+3,023
+117% +$664K 0.01% 289
2024
Q2 		$524K Sell
2,573
-9
-0.3% -$1.83K 0.01% 464
2024
Q1 		$564K Sell
2,582
-70
-3% -$15.4K 0.01% 442
2023
Q4 		$603K Buy
2,652
+93
+4% +$19.5K 0.01% 410
2023
Q3 		$514K Sell
2,559
-348
-12% -$73.4K 0.01% 426
2023
Q2 		$603K Buy
2,907
+943
+48% +$183K 0.01% 408
2023
Q1 		$387K Buy
1,964
+177
+10% +$36.4K ﹤0.01% 523
2022
Q4 		$361K Sell
1,787
-255
-12% -$49.8K ﹤0.01% 524
2022
Q3 		$359K Sell
2,042
-78
-4% -$16K 0.01% 480
2022
Q2 		$427K Sell
2,120
-38
-2% -$8.1K 0.01% 452
2022
Q1 		$489K Sell
2,158
-753
-26% -$177K 0.01% 425
2021
Q4 		$786K Sell
2,911
-2,314
-44% -$573K 0.01% 299
2021
Q3 		$1.26M Buy
5,225
+32
+0.6% +$8.06K 0.02% 190
2021
Q2 		$1.23M Sell
5,193
-1,498
-22% -$341K 0.02% 194
2021
Q1 		$1.47M Sell
6,691
-33,496
-83% -$6.72M 0.02% 149
2020
Q4 		$7.03M Buy
40,187
+3,939
+11% +$680K 0.09% 47
2020
Q3 		$5.86M Buy
36,248
+476
+1% +$75.4K 0.09% 48
2020
Q2 		$5.11M Buy
35,772
+5,613
+19% +$777K 0.09% 51
2020
Q1 		$3.27M Buy
30,159
+2,392
+9% +$345K 0.07% 60
2019
Q4 		$4.04M Buy
27,767
+619
+2% +$89.4K 0.06% 68
2019
Q3 		$3.92M Buy
27,148
+995
+4% +$145K 0.06% 68
2019
Q2 		$3.88M Buy
26,153
+474
+2% +$66.1K 0.06% 65
2019
Q1 		$3.38M Sell
25,679
-137
-0.5% -$16.9K 0.06% 67
2018
Q4 		$2.8M Sell
25,816
-3,446
-12% -$462K 0.06% 70
2018
Q3 		$4.37M Buy
29,262
+1,320
+5% +$201K 0.08% 57
2018
Q2 		$4.31M Buy
27,942
+1,213
+5% +$183K 0.08% 58
2018
Q1 		$3.71M Buy
26,729
+831
+3% +$122K 0.07% 63
2017
Q4 		$3.55M Buy
25,898
+25,853
+57,451% +$3.42M 0.07% 66
2017
Q3 		$6K Buy
+45
New +$6K ﹤0.01% 672

Other funds holding LH

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
DIA
Davidson Investment Advisors Great Falls, Montana $2.45B AUM 21.8% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
ET
Equitable Trust Nashville, Tennessee $2.4B AUM 30.76% 1-Year Est. Return

Greenleaf Trust's LH Position: Q2 2026 in Review

Greenleaf Trust increased its Labcorp (LH) stake by 10% in Q2 2026, buying an estimated $113K and bringing the position to 4,592 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #299.

Greenleaf Trust first reported a position in LH in Q3 2017 and has held it in 36 quarters since. The position peaked at $7.03M in Q4 2020. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Greenleaf Trust held 4,592 shares of Labcorp worth $1.29M as of Q2 2026.
  • Greenleaf Trust bought 428 Labcorp shares in Q2 2026, an estimated $113K.
  • Labcorp made up 0.01% of Greenleaf Trust's portfolio in Q2 2026, its #299 holding.
  • Greenleaf Trust first reported a position in Labcorp in Q3 2017 and has held it in 36 quarters since.
  • Greenleaf Trust's Labcorp position peaked at $7.03M in Q4 2020.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.